LENZ THERAPEUTICS, INC. Operating Cash Flow
LENZ THERAPEUTICS, INC. (LENZ) reported Operating Cash Flow of -$72.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$38.71M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$33.58M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$33.02M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.59M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$69.17M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$59.39M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$60.38M.
- LENZ THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$87.98M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$38.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$72.30M 10-Q · filed 2026-08-11 | -$105.32M derived: sum of 3 quarters · filed 2026-08-11 | -$113.91M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | -$33.58M 10-Q · filed 2026-05-11 | -$66.61M derived: sum of 2 quarters · filed 2026-05-11 | -$75.19M derived: sum of 3 quarters · filed 2026-05-11 | -$86.70M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | -$33.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$41.61M derived: sum of 2 quarters · filed 2026-03-24 | -$53.12M derived: sum of 3 quarters · filed 2026-08-11 | -$69.17M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$8.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$20.10M derived: sum of 2 quarters · filed 2026-08-11 | -$36.15M 10-Q · filed 2025-11-05 | -$45.22M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | -$11.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$27.56M 10-Q · filed 2026-08-11 | -$36.63M derived: sum of 3 quarters · filed 2026-08-11 | -$47.22M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | -$16.05M 10-Q · filed 2026-05-11 | -$25.13M derived: sum of 2 quarters · filed 2026-05-11 | -$35.71M derived: sum of 3 quarters · filed 2026-05-11 | -$51.50M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$9.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$19.66M derived: sum of 2 quarters · filed 2026-03-24 | -$35.45M derived: sum of 3 quarters · filed 2026-03-24 | -$59.39M 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | -$10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$26.38M derived: sum of 2 quarters · filed 2025-11-05 | -$50.31M 10-Q · filed 2025-11-05 | -$71.28M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$15.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$39.73M 10-Q · filed 2025-07-30 | -$60.70M derived: sum of 3 quarters · filed 2025-07-30 | -$73.79M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2024-03-31 | -$23.94M 10-Q · filed 2025-05-07 | -$44.91M derived: sum of 2 quarters · filed 2025-05-07 | -$57.99M derived: sum of 3 quarters · filed 2025-05-07 | -$71.52M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$20.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$34.06M derived: sum of 2 quarters · filed 2025-03-19 | -$47.58M derived: sum of 3 quarters · filed 2025-03-19 | -$60.38M 10-K · filed 2025-03-19 | -$90.01M 10-K · filed 2024-02-27 | |||
| 2023-09-30 | -$13.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$26.61M derived: sum of 2 quarters · filed 2024-11-06 | -$39.41M 10-Q · filed 2024-11-06 | -$44.13M 10-Q · filed 2023-11-13 | -$61.84M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$13.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$26.32M 10-Q · filed 2024-08-14 | -$34.73M 10-Q · filed 2023-08-14 | -$48.75M derived: sum of 3 quarters · filed 2024-08-14 | -$70.97M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$12.80M 10-Q · filed 2024-05-08 | -$21.07M 10-Q · filed 2023-05-11 | -$35.23M derived: sum of 2 quarters · filed 2024-05-08 | -$57.44M derived: sum of 3 quarters · filed 2024-05-08 | -$79.54M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | -$22.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$44.65M derived: sum of 2 quarters · filed 2024-02-27 | -$66.74M derived: sum of 3 quarters · filed 2024-02-27 | -$87.98M 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | -$22.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$44.31M derived: sum of 2 quarters · filed 2023-11-13 | -$65.55M 10-Q · filed 2023-11-13 | -$81.14M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$22.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$43.33M 10-Q · filed 2023-08-14 | -$58.93M derived: sum of 3 quarters · filed 2023-08-14 | -$74.34M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$21.24M 10-Q · filed 2023-05-11 | -$36.83M derived: sum of 2 quarters · filed 2023-05-11 | -$52.25M derived: sum of 3 quarters · filed 2023-05-11 | -$66.03M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$15.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$31.01M derived: sum of 2 quarters · filed 2023-03-20 | -$44.79M derived: sum of 3 quarters · filed 2023-03-20 | -$52.85M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$15.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$29.20M derived: sum of 2 quarters · filed 2022-11-09 | -$37.26M 10-Q · filed 2022-11-09 | -$42.53M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$13.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$21.84M 10-Q · filed 2022-08-11 | -$27.11M derived: sum of 3 quarters · filed 2022-08-11 | -$29.61M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$8.06M 10-Q · filed 2022-05-12 | -$13.33M derived: sum of 2 quarters · filed 2022-05-12 | -$15.82M derived: sum of 3 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | -$5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$7.76M derived: sum of 2 quarters · filed 2022-03-21 | -$8.72M 10-K · filed 2022-03-21 | |||||
| 2020-09-30 | -$2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.45M 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$957.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |